Relief Therapeutics Holding Stock Technical Analysis
| RLFTY Stock | USD 4.80 0.20 4.00% |
As of the 21st of December, Relief Therapeutics holds the Semi Deviation of 6.38, risk adjusted performance of 0.1152, and Coefficient Of Variation of 748.02. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Relief Therapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Relief Therapeutics, which can be compared to its competitors.
Relief Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Relief, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ReliefRelief |
Relief Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Relief Therapeutics Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Relief Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Relief Therapeutics Trend Analysis
Use this graph to draw trend lines for Relief Therapeutics Holding. You can use it to identify possible trend reversals for Relief Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Relief Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Relief Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Relief Therapeutics Holding applied against its price change over selected period. The best fit line has a slop of 0.0034 , which may suggest that Relief Therapeutics Holding market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.44, which is the sum of squared deviations for the predicted Relief Therapeutics price change compared to its average price change.About Relief Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Relief Therapeutics Holding on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Relief Therapeutics Holding based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Relief Therapeutics price pattern first instead of the macroeconomic environment surrounding Relief Therapeutics. By analyzing Relief Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Relief Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Relief Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Relief Therapeutics December 21, 2024 Technical Indicators
Most technical analysis of Relief help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Relief from various momentum indicators to cycle indicators. When you analyze Relief charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1152 | |||
| Market Risk Adjusted Performance | (2.40) | |||
| Mean Deviation | 6.48 | |||
| Semi Deviation | 6.38 | |||
| Downside Deviation | 9.41 | |||
| Coefficient Of Variation | 748.02 | |||
| Standard Deviation | 10.61 | |||
| Variance | 112.5 | |||
| Information Ratio | 0.1307 | |||
| Jensen Alpha | 1.42 | |||
| Total Risk Alpha | 1.11 | |||
| Sortino Ratio | 0.1472 | |||
| Treynor Ratio | (2.41) | |||
| Maximum Drawdown | 65.15 | |||
| Value At Risk | (15.07) | |||
| Potential Upside | 17.05 | |||
| Downside Variance | 88.58 | |||
| Semi Variance | 40.74 | |||
| Expected Short fall | (9.88) | |||
| Skewness | 1.9 | |||
| Kurtosis | 7.02 |
Additional Tools for Relief OTC Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.